Project Number 1U01AG056437-01A1 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Long-term toxicology studies for Posiphen; 6 month in rats and 9 months in dogs Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) i. Proteostasis/Proteinopathies Researcher and Organization Principal Investigator MACCECCHINI, MARIA Principal Investigator First Name MARIA Principal Investigator Last Name MACCECCHINI Awardee Organization QR PHARMA INC. Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-820: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) FY Overall Cost $953,849 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YUAN, JEAN
